Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

✍ Scribed by Marianne E Pavel; John D Hainsworth; Eric Baudin; Marc Peeters; Dieter Hörsch; Robert E Winkler; Judith Klimovsky; David Lebwohl; Valentine Jehl; Edward M Wolin; Kjell Öberg; Eric Van Cutsem; James C Yao

• Book ID: 117309500
• Publisher: The Lancet
• Year: 2011
• Tongue: English
• Weight: 392 KB
• Volume: 378
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(11)61742-x